Definitive Contract W81XWH21C0037
Award Date
6/14/21
Potential Completion Date
8/13/23
Potential Value
$1.5M
Federal Agency
Medical Command
Awardee
Infrascan Inc.
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Philadelphia, PA 19104, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
6
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
SBIR Program Phase II Action
Primary Consortia Member
Not listed
Similar Awards
The U.S. Department of the Army Medical Command awarded a $4,044,874.84 firm fixed-price contract to Infrascan Inc., a small business medical device manufacturer, for the continued development of a portable brain hematoma detector device. This contract, which has no set-aside designation, aims to advance the Army's medical capabilities by providing mobile brain injury screening tools for use in operational settings. The original contract opportunity, a Special Notice, sought services for the...
<p>The Department of the Army Medical Command awarded a $3,330,712.44 Firm Fixed Price contract to Infrascan Inc., a for-profit manufacturer, for the development and support of a POI-TBI (Portable Optical Imaging for Traumatic Brain Injury) device. The contract was awarded on September 27, 2017 and has a completion date of September 26, 2019. This contract is not associated with a larger vehicle and does not have a set-aside designation.</p>
This is a delivery order awarded to Infrascan Inc., a medical device company, by the U.S. Marine Corps under a larger contract vehicle. The award, worth $209,818.19, is for Other Direct Costs (ODC) related to the Small Business Innovation Research (SBIR) Program Phase III development of Infrascan's portable near-infrared technology to detect traumatic brain injuries. This technology has been the subject of prior SBIR Phase II and sole source contracts with the U.S. Army Medical Command and...
The Department of the Army Medical Command awarded a firm-fixed-price purchase order to Wetware Biosystems LLC, a self-certified small disadvantaged business, for the SBIR Program Phase I solicitation titled "IRONCROWN: A Novel Medical Device for the Prehospital Diagnosis and Treatment of Traumatic Brain Injury". The award, totaling $249,975.56, has a completion date of March 15, 2022 and is set aside for small businesses. The award supports research and development of a medical device...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the Department of the Army Medical Command to Neurotheranostics Inc., a minority-owned small disadvantaged business. The contract, valued at $146,079.20, is for research to develop a point-of-injury therapy to maintain and stabilize moderate-to-severe traumatic brain injury (TBI). The contract is a firm-fixed-price definitive contract, with the work to be performed in Walled Lake, Michigan. This SBIR Phase I contract...
The Department of the Army Medical Command awarded a fixed-price level-of-effort research and development contract to Brainscope Co Inc., a for-profit manufacturer of goods. The $4,500,000.00 contract, awarded on August 31, 2018, is for the development of a multimodal brain function biomarker for the rapid, objective assessment of mildly head-injured individuals. The contract was solicited through Broad Agency Announcement W81XWH18SBAA1 and has a performance period ending on March 30, 2022....
This contract award to Oculogica Inc., a woman-owned small business, provides $1,999,986.00 in funding from the Defense Health Agency for the research and development of a highly portable device to assess mild traumatic brain injury in deployed and far-forward military settings. The contract, which runs through December 2025, supports the Congressionally Directed Medical Research Programs' Combat Readiness-Medical Research Program's efforts to advance both military and civilian medical...
The U.S. Army Medical Research Acquisition Activity (USAMRAA) awarded a $2,743,260.95 cost-plus-fixed-fee definitive contract to Q30 Sports Science, LLC (doing business as Q30 Innovations) to develop a small wearable traumatic brain injury (TBI) prevention device. The contract has a period of performance through March 2, 2026 and was not set aside for any specific business category. The contract stems from a sole-source procurement notice seeking two Applied Biosystems 3500XL Genetic Analyzer...
This is a $2,093,995.00 fixed-price level of effort Definitive Contract awarded by the Defense Health Agency to Medicortex Finland OYJ, a for-profit limited liability company based in Finland. The contract is for the purpose of "Rapid Detection of Mild Traumatic Brain Injury in a Noninvasive Body Fluid Sample" for the United States Army Medical Research and Development Command. The contract has an ultimate completion date of March 31, 2025 and was awarded on September 19, 2022. The...
This contract was awarded by the Defense Health Agency to Jtap Technologies, LLC, a self-certified small disadvantaged business, for a Phase II Small Business Innovation Research (SBIR) project titled "Point of Injury Device to Maintain and Stabilize Moderate-Severe Traumatic Brain Injury (TBI) Casualties." The award, with a potential value of $833,060.00, is for a definitive, firm-fixed price contract. The place of performance is Yorktown, VA. The contract was set aside for total...